Some AI researchers hailed DeepSeek’s R1 as a breakthrough on the same level as DeepMind’s AlphaZero, a 2017 model that became superhuman at the board games Chess and Go by purely playing against itself and improving, rather than observing any human games.
Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis. "We'll hopefully have some AI-designed drugs in clinical trials by the end of the year,
This new approach, based on natural selection, dramatically improves the reliability of large language models for practical tasks like trip planning. Here's how it works.
Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. “We’ll hopefully have
The Chinese startup DeepSeek released an AI reasoning model that appears to rival the abilities of a frontier model from OpenAI, the maker of ChatGPT.
The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.
DeepSeek—built in two months with a lean team and outdated chips—just dethroned ChatGPT as the #1 app on the US App Store. This isn't just a wake-up call; it's a siren blaring in the ears of every Indian founder,
Pharmaceutical Technology on MSN3d
The AI advantage in discovering new medicines
With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.
FREE TO READ] Chinese artificial intelligence group’s use of ‘reinforcement learning’ and ‘small language models’ leads to breakthroughs
With "Mind Evolution" LLMs can use search and genetic algorithms to generate and combine different solutions and find the optimal one.
The government wants these AI experts to mentor Indian startups and young researchers. Some leading Indian-origin AI experts have shown interest in returning to India
OpenAI CEO and co-founder Sam Altman is under fresh scrutiny after an old video resurfaced, showing him dismissing the feasibility of building a competitive artificial intelligence (AI) model with a budget of $10 million.